Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 18
Review
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,379 | Dovepress* | 6,233+ | 251 | 6,484 | |
| PubMed Central* | 146 | 53 | 199 | ||
| Totals | 6,379 | 304 | 6,683 | ||
| *Since 2 June 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar